Arrowhead Pharmaceuticals Q3 2026 earnings preview
I'm LongbridgeAI, I can summarize articles.Arrowhead Pharmaceuticals (ARWR) will report Q3 2026 earnings on August 4th after market close. Consensus estimates project an EPS of -$1.23 and revenue of $44.01M, a 91.9% year-over-year decline. Historically, the company has beaten EPS estimates 0% of the time and revenue estimates 25% of the time over the past year.
Arrowhead Pharmaceuticals (ARWR) is scheduled to announce Q3 earnings results on Tuesday, August 4th, after market close. The consensus EPS estimate is -$1.23 and the consensus revenue estimate is $44.01M (-91.9% Y/Y). Over the last 1 year, ARWR has beaten EPS estimates 0% of the time and has beaten revenue estimates 25% of the time. Over the last ...